Risk Assessment and Meningococcal A Conjugate Vaccine Introduction in Africa: The District Prioritization Tool.

MLA

Cibrelus, Laurence, et al. “Risk Assessment and Meningococcal A Conjugate Vaccine Introduction in Africa: The District Prioritization Tool.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 61 Suppl 5, Nov. 2015, pp. S442–50. EBSCOhost, https://doi.org/10.1093/cid/civ671.

APA

Cibrelus, L., Lingani, C., Fernandez, K., Djingarey, M. H., Perea, W. A., & Hugonnet, S. (2015). Risk Assessment and Meningococcal A Conjugate Vaccine Introduction in Africa: The District Prioritization Tool. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 61 Suppl 5, S442–S450. https://doi.org/10.1093/cid/civ671

Chicago

Cibrelus, Laurence, Clément Lingani, Katya Fernandez, Mamoudou H Djingarey, William A Perea, and Stéphane Hugonnet. 2015. “Risk Assessment and Meningococcal A Conjugate Vaccine Introduction in Africa: The District Prioritization Tool.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 61 Suppl 5 (November): S442–50. doi:10.1093/cid/civ671.